Hoth Therapeutics Inc. (HOTH)
Hoth Therapeutics Statistics
Share Statistics
Hoth Therapeutics has 13.17M shares outstanding. The number of shares has increased by 145.35% in one year.
| Shares Outstanding | 13.17M |
| Shares Change (YoY) | 145.35% |
| Shares Change (QoQ) | 90.44% |
| Owned by Institutions (%) | 0% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 1,170 |
| FTD / Avg. Volume | 0.17% |
Short Selling Information
The latest short interest is 222.49K, so 1.69% of the outstanding shares have been sold short.
| Short Interest | 222.49K |
| Short % of Shares Out | 1.69% |
| Short % of Float | 1.7% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is -0.58 and the forward PE ratio is -1.92. Hoth Therapeutics's PEG ratio is 0.01.
| PE Ratio | -0.58 |
| Forward PE | -1.92 |
| PS Ratio | 0 |
| Forward PS | 0.1 |
| PB Ratio | 0.69 |
| P/FCF Ratio | -0.68 |
| PEG Ratio | 0.01 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Hoth Therapeutics.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.2, with a Debt / Equity ratio of 0.
| Current Ratio | 9.2 |
| Quick Ratio | 9.2 |
| Debt / Equity | 0 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-4,094,150 |
| Employee Count | 2 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -27.64% in the last 52 weeks. The beta is 0.64, so Hoth Therapeutics's price volatility has been higher than the market average.
| Beta | 0.64 |
| 52-Week Price Change | -27.64% |
| 50-Day Moving Average | 0.96 |
| 200-Day Moving Average | 0.94 |
| Relative Strength Index (RSI) | 51.19 |
| Average Volume (20 Days) | 677,739 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -8.22M |
| Net Income | -8.19M |
| EBITDA | -8.22M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -1.28 |
Balance Sheet
The company has 7.04M in cash and 31.07K in debt, giving a net cash position of 7.01M.
| Cash & Cash Equivalents | 7.04M |
| Total Debt | 31.07K |
| Net Cash | 7.01M |
| Retained Earnings | -60.41M |
| Total Assets | 7.71M |
| Working Capital | 6.81M |
Cash Flow
In the last 12 months, operating cash flow was -6.98M and capital expenditures 0, giving a free cash flow of -6.98M.
| Operating Cash Flow | -6.98M |
| Capital Expenditures | n/a |
| Free Cash Flow | -6.98M |
| FCF Per Share | -1.09 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
HOTH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for HOTH is $4.5, which is 405.6% higher than the current price. The consensus rating is "Buy".
| Price Target | $4.5 |
| Price Target Difference | 405.6% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
Stock Splits
The last stock split was on Oct 26, 2022. It was a backward split with a ratio of 1:25.
| Last Split Date | Oct 26, 2022 |
| Split Type | backward |
| Split Ratio | 1:25 |
Scores
| Altman Z-Score | -5.41 |
| Piotroski F-Score | 1 |